CA Stock MarketDetailed Quotes
LSL LSL Pharma Group Inc
- 0.475
- 0.0000.00%
15min DelayMarket Closed Jul 26 16:00 ET
54.88MMarket Cap-14393P/E (TTM)
0.000High0.000Low0Volume0.000Open0.475Pre Close0.00Turnover0.55052wk High0.00%Turnover Ratio115.53MShares0.35052wk Low-0.033EPS TTM36.43MFloat Cap1.000Historical HighLossP/E (Static)76.69MShs Float0.350Historical Low-0.11EPS LYR0.00%Amplitude--Dividend TTM3.74P/B1Lot Size--Div YieldTTM
LSL Pharma Group Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 59.06%-1.91M | -123.45%-7.07M | 59.42%-964.49K | -133.28%-1.5M | 101.44%58.25K | -219.19%-4.67M | -191.62%-3.16M | -271.56%-2.38M | -642.48K | -4.06M |
| Net income from continuing operations | 94.82%-280K | -5.09%-8.47M | 84.22%-475.95K | 48.04%-762.27K | 68.92%-1.83M | -333.60%-5.4M | -353.71%-8.06M | -151.70%-3.02M | ---1.47M | ---5.89M |
| Depreciation and amortization | 34.14%334K | 7.83%1.13M | -17.70%244.34K | 39.10%346.79K | 14.69%288.88K | 0.04%249K | 7.50%1.05M | 8.82%296.9K | --249.32K | --251.88K |
| Remuneration paid in stock | --0 | --2.12M | ---854.03K | --0 | --854.03K | --2.12M | --0 | --0 | --0 | --0 |
| Other non cashItems | -70.25%459K | 229.09%2.9M | 26.02%595.05K | 24.90%426.07K | -92.31%331.88K | 136.30%1.54M | -43.74%880K | 7.15%472.2K | --341.14K | --4.32M |
| Change In working capital | 23.59%-2.42M | -259.54%-4.74M | -266.36%-473.91K | -744.82%-1.51M | -78.08%414.26K | -424.86%-3.17M | 249.02%2.97M | 74.68%-129.36K | --234.07K | --1.89M |
| -Change in receivables | -121.95%-728K | ---- | ---- | 68.31%-294.33K | 166.01%140.2K | -161.47%-328K | ---- | ---- | ---928.75K | ---212.39K |
| -Change in inventory | 48.90%-162K | ---- | ---- | -18.62%539.01K | -150.14%-1.13M | -167.97%-317K | ---- | ---- | --662.34K | ---453.1K |
| -Change in prepaid assets | -134.63%-725K | ---- | ---- | 69.32%-10.57K | 244.53%122.51K | -555.98%-309K | ---- | ---- | ---34.45K | ---84.76K |
| -Change in payables and accrued expense | 63.67%-808K | ---- | ---- | -479.17%-1.74M | -52.12%1.27M | -14,713.31%-2.22M | ---- | ---- | --459.81K | --2.65M |
| -Change in other working capital | ---- | ---- | ---- | --0 | --16.76K | -12.51%7K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 59.06%-1.91M | -123.45%-7.07M | 59.42%-964.49K | -133.28%-1.5M | -89.73%58.25K | -555.05%-4.67M | -191.62%-3.16M | -271.56%-2.38M | ---642.48K | --567.35K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -381.82%-689K | -2.01%-1.02M | 223.00%656.65K | -598.77%-1.29M | 70.67%-240.55K | 26.82%-143K | 4.11%-997K | 299.70%203.3K | -184.63K | -820.27K |
| Net PPE purchase and sale | -360.17%-543K | 34.20%-656K | 86.28%854.12K | -529.34%-1.16M | 74.52%-230.2K | 67.88%-118K | -8.99%-997K | 221.22%458.5K | ---184.63K | ---903.46K |
| Net intangibles purchas and sale | -484.00%-146K | ---361K | ---311K | ---25K | --0 | ---25K | --0 | --0 | --0 | --0 |
| Net other investing changes | ---- | ---- | ---- | ---103.19K | ---- | ---- | ---- | ---- | --0 | --83.19K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -381.82%-689K | -2.01%-1.02M | 223.00%656.65K | -598.77%-1.29M | 70.67%-240.55K | 26.82%-143K | 4.11%-997K | 299.70%203.3K | ---184.63K | ---820.27K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -53.94%2.56M | 136.70%8.1M | -83.53%344.43K | 212.57%2.25M | -105.46%-50.07K | 1,916.43%5.55M | 263.77%3.42M | 118.67%2.09M | 718.75K | 916.25K |
| Net issuance payments of debt | 133.23%818K | -29.78%1.98M | -70.61%1.01M | 617.00%2.96M | 155.82%480.33K | -1,483.30%-2.46M | 414.12%2.82M | 711.87%3.43M | --412.46K | ---860.54K |
| Net common stock issuance | -79.02%1.99M | 299.79%9.46M | 99.97%-97 | --0 | -99.99%97 | 126,073.33%9.46M | -10.51%2.37M | -138.46%-350K | --1.2M | --1.51M |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Interest paid (cash flow from financing activities) | 60.16%-100K | -17.78%-1.04M | 55.45%-217.01K | -67.16%-307.73K | -421.63%-264.26K | 14.61%-251K | 29.99%-883K | -23.46%-487.14K | ---184.1K | --82.16K |
| Net other financing activities | 87.88%-145K | -160.25%-2.31M | 10.78%-445.82K | 42.97%-402.95K | -246.18%-266.23K | -978.37%-1.2M | 10.56%-888K | -2,794.12%-499.68K | ---706.61K | --182.13K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -53.94%2.56M | 136.70%8.1M | -83.53%344.43K | 212.57%2.25M | -105.46%-50.07K | 1,916.43%5.55M | 263.77%3.42M | 118.67%2.09M | --718.75K | --916.25K |
| Net cash flow | ||||||||||
| Beginning cash position | --8K | --0 | -134.58%-28.59K | 168.90%513.64K | 257.95%746K | --0 | -61.52%741K | -84.29%82.66K | --191.01K | ---472.31K |
| Current changes in cash | -105.50%-41K | 101.08%8K | 144.27%36.59K | -400.42%-542.22K | -135.03%-232.36K | 161.48%746K | 37.44%-741K | -138.50%-82.65K | ---108.35K | --663.33K |
| End cash Position | -104.42%-33K | --8K | --8K | -134.58%-28.59K | 168.90%513.64K | 257.95%746K | --0 | --0 | --82.66K | --191.01K |
| Free cash from | 45.94%-2.6M | -94.35%-8.09M | 78.03%-421.38K | -224.71%-2.69M | 48.84%-171.95K | -345.36%-4.81M | -108.08%-4.16M | -88.45%-1.92M | ---827.11K | ---336.11K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg